“ab fubinaca”的搜索结果

7 个项目

每页

设置降序顺序
  1. AZD5153 6-Hydroxy-2-naphthoic acid

    Catalog No. A21852
    Quick View
    BET/BRD4 bromodomain inhibitor
    AZD5153 6-Hydroxy-2-naphthoic acid is the 6-Hydroxy-2-naphthoic acid of AZD5153. AZD5153 is a potent, selective, and orally available BET/BRD4 bromodomain inhibitor; disrupts BRD4 with an IC50 of 1.7 nM. 了解更多
  2. GS-626510

    Catalog No. A13305
    Quick View
    BET family bromodomains inhibitor
    GS-626510 is a potent, and orally bioavailable BET family bromodomains inhibitor, with Kd values of 0.59-3.2 nM for BRD2/3/4, with IC50 values of 83 nM and 78 nM foe BD1 and BD2, respectively. 了解更多
  3. CD235

    Catalog No. A19115
    Quick View
    BET bromodomain inhibitor
    CD235 is a structurally similar analogue of CD161. CD161 is a potent and orally bioavailable BET bromodomain inhibitor. 了解更多
  4. GNE-207

    Catalog No. A18844
    Quick View
    CBP bromodomain inhibitor
    GNE-207 is a novel, potent, and orally bioavailable inhibitor of the bromodomain of CBP. GNE-207 has excellent CBP potency (CBP IC50?=?1?nM, MYC EC50?=?18?nM), and it exhibits a good pharmacokinetic profile. 了解更多
    • 最新产品

    Mivebresib (ABBV-075)

    Catalog No. A17226
    Quick View
    BET inhibitor
    Mivebresib, also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-containing proteind) with potential antineoplastic activity. 了解更多
  5. ABBV-744

    Catalog No. A16831
    Quick View
    BET bromodomain 抑制剂
    ABBV-744是一种BDII选择性BET溴结构域抑制剂,正在研究中,用于治疗AML和对去势抵抗的前列腺癌。 了解更多
  6. Apabetalone (RVX-208)

    Catalog No. A13956
    Quick View
    BET bromodomain 抑制剂
    RVX-208是一种有效的BET溴结构域抑制剂,对BD2的IC50为0.510 uM,是BD1选择性的170倍。 了解更多

7 个项目

每页

设置降序顺序
Rewards